Trial Profile
A phase Ib study of LX 2931 in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2008
Price :
$35
*
At a glance
- Drugs ACB2003.4 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Lexicon Pharmaceuticals
- 25 Oct 2008 New trial record.
- 25 Oct 2008 Results presented at the American College of Rheumatology 2008 annual meeting.